Search bioRxivSearch

bioRxiv · 10.1101/809749

State anxiety biases estimates of uncertainty during reward learning in volatile environments

Abstract

Previous research established that clinical anxiety impairs decision making and that high trait anxiety interferes with learning rates. Less understood are the effects of temporary anxious states on learning and decision making in healthy populations. Here we follow proposals that anxious states in healthy individuals elicit a pattern of aberrant behavioural, neural, and physiological responses comparable with those found in anxiety disorders, particularly when processing uncertainty in unstable environments. In our study, both a state anxious and a control group learned probabilistic stimulus-outcome mappings in a volatile task environment while we recorded their electrophysiological (EEG) signals. By using a hierarchical Bayesian model, we assessed the effect of state anxiety on Bayesian belief updating with a focus on uncertainty estimates. State anxiety was associated with an underestimation of environmental and informational uncertainty, and an increase in uncertainty about volatility estimates. Anxious individuals deemed their beliefs about reward contingencies to be more precise and to require less updating, ultimately leading to impaired reward-based learning. We interpret this pattern as evidence that state anxious individuals are less tolerant to informational uncertainty about the contingencies governing their environment and more uncertain about the level of stability of the world itself. Further, we tracked the neural representation of belief update signals in the trial-by-trial EEG amplitudes. In control participants, both lower-level precision-weighted prediction errors (pwPEs) about the reward outcomes and higher-level volatility-pwPEs were represented in the ERP signals with an anterior distribution. A different pattern emerged under state anxiety, where a neural representation of pwPEs was only found for updates about volatility. Expanding previous computational work on trait anxiety, our findings establish that temporary anxious states in healthy individuals impair reward-based learning in volatile environments, primarily through changes in uncertainty estimates and potentially a degradation of the neuronal representation of hierarchically-related pwPEs, considered to play a central role in current Bayesian accounts of perceptual inference and learning.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hein, T. P., Weber, L. A., de Fockert, J., Herrojo Ruiz, M.. 2019-10-17. State anxiety biases estimates of uncertainty during reward learning in volatile environments. https://doi.org/10.1101/809749

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience